Liraglutide injection: Clinical Trials

7 trials of Liraglutide injection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting, 1 unknown, 1 withdrawn. 2 Phase 1, 2 Phase 3, 2 Phase 4, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2
Phase 32Recruiting 1, Withdrawn 1
Phase 42Completed 2
Not applicable1Unknown 1
Phase 21Withdrawn 1

Follow Liraglutide injection: new trials by email Literature Review of Liraglutide injection trials Research Report on Liraglutide injection

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Liraglutide in Preventing Delirium in Diabetic Elderly After Cardiac Surgery
Liraglutide injection, Placebo injection - Delirium, Postoperative
Phase 3RecruitingThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School2602024-11-192024-12-20
Research on Timing of Liraglutide Therapy in Patients With Obesity After Metabolic Surgery
Liraglutide injection, Diet and exercise guidelines - Obesity, Weight Loss
Phase 4CompletedThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1002023-09-012026-01-28
POSE2.0 With GLP-1 Agonist for Obesity Management
POSE2.0 Endoscopic Gastric Remodeling, Liraglutide injection - Obesity
Not applicableUnknownEmirates Health Services (EHS)502023-01-162023-01-30
Liraglutide Effectiveness in Preoperative Weight-loss for Bariatric-metabolic Surgery
Liraglutide injection - Weight Loss, Bariatric Surgery Candidate
Phase 4CompletedHospital Civil Juan I. Menchaca372022-12-182024-01-18
A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
Liraglutide injection, Liraglutide injection(Victoza®) - Therapeutic Equivalency
Phase 1CompletedThe Affiliated Hospital of Qingdao University322021-07-162022-02-07
Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
Liraglutide Injection, Megestrol Acetate 160 MG - Atypical Endometrial Hyperplasia, Obese
Phase 2 / Phase 3WithdrawnXiaojun Chen2021-03-202024-09-26
Human Bioequivalence Test of Liraglutide Injection
Liraglutide injection, Victoza - Type 2 Diabetes
Phase 1CompletedChia Tai Tianqing Pharmaceutical Group Co., Ltd.282019-05-212021-08-31

Conditions studied

Obesity (3)  ·  Weight Loss (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Emergence Delirium (1)  ·  Endometrial Hyperplasia (1)  ·  Infertility (1)  ·  Obesity, Morbid (1)

Sponsors

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School (2)  ·  Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)  ·  Emirates Health Services (EHS) (1)  ·  Hospital Civil Juan I. Menchaca (1)  ·  The Affiliated Hospital of Qingdao University (1)  ·  Xiaojun Chen (1)

Countries

China (4)  ·  Mexico (1)  ·  United Arab Emirates (1)

Top investigators

Dongjin Wang, PhD,MD (1)  ·  Maryam AlKhatry, MD (1)

Results publications

PMID 36883362